“Overall Survival and Role of Programmed Death Ligand 1 Expression in Patients With Metastatic Non-Small-Cell Lung Cancer and Immunotherapy: An Observational Study from Central Switzerland”. Swiss Medical Weekly, vol. 153, no. 1, Jan. 2023, p. 40039, https://doi.org/10.57187/smw.2023.40039.